The present value of human life losses associated with COVID-19 and likely cost savings from vaccination in Kenya

Author:

Kirigia JosesORCID,Mwabu Germano,Muthuri Rose Nabi Deborah KarimiORCID

Abstract

Background: The study estimates the total present value (TPVKENYA ) of human lives lost due to COVID-19, total indirect costs attributed to COVID-19 mortality, total direct costs of all COVID-19 cases, and projected cost savings due to COVID-19 vaccination as of 25 July 2022. Methods: We used a human capital approach (HKA) model to estimate TPVKENYA . The indirect cost of COVID-19 (ICi=1,..,6)  for each of the six productive age groups equals the present value multiplied by the relevant employment-to-population ratio. The direct cost (DCi=1,..,4) for each of the four disease severity categories (asymptomatic, mild/moderate, severe, critical) is the product of the number of COVID-19 cases in a severity category and the average total direct cost per patient. The total direct cost saving equals the number of infections averted with vaccination multiplied by the average total direct cost per patient treated. The total indirect cost saving equals the number of COVID-19 deaths prevented with vaccination multiplied by the average total indirect cost per death. Results: The cumulative 5670 human life losses had a TPVKENYA  of Int$268,408,687 and an average total present value of Int$47,338 per human life. A re-run of the HKA model with (a) discount rates of 5% and 10% reduced TPVKENYA by 16% and 39%, respectively; (b) Africa's highest life expectancy of 78.76 years and world's highest life expectancy of 88.17 years increased TPVKENYA by 79% and 129%, respectively; (c) excess mortality of 180,215 increased TPVKENYA by 3,078%. Total indirect and direct costs of COVID-19 were Int$36,833 per death and Int$1,648.2 per patient/case, respectively. The 30% target population's COVID-19 vaccination coverage may have saved Kenya a total cost of Int$ 1,400,945,809.  Conclusions: The pandemic continues to erode Kenya's human health and economic development. However, scaling up COVID-19 vaccination coverage would save Kenya substantial direct and indirect costs.

Publisher

F1000 Research Ltd

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference38 articles.

1. Countries in the world by population.,2022

2. COVID-19 Coronavirus Pandemic database: Last updated: July 25, 2022, 06:18 GMT.

3. Global Health Observatory. International Health Regulations (IHR SPAR): All capacities.

4. Kenya Literacy Rate.

5. The Global Hunger Index.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3